MII IG Symptom
2027.0.0-ballot -
Germany
This page is part of the MII Implementation Guide Symptom (v2027.0.0-ballot: 2027 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
This page includes translations from the original source language in which the guide was authored. Information on these translations and instructions on how to provide feedback on the translations can be found [here](translationinfo.html).
Written during migration - review before release. This page describes scenarios for applying the Symptoms/clinical phenotype module. The subject-matter relationships to other KDS modules are described in the Guidance for Implementers; the information model on the pages Logical Models and UML Diagrams.
Measurements that belong together in content can be represented as components of a superordinate measurement:
The reference structure of clinically related measurements can be represented by hierarchical linking into part–whole structures. Likewise, the type of measurement and the performance of measurements (Procedure) can be represented in the Observation.
The distinction between findings (Condition) and measurements/observations (Observation) is often not exactly possible; in the borderline area a representation as Observation would often be preferred over the Condition. A determination can only be made for a concrete application context (in a specific implementation guide).
Findings can be related to the evidence / the reason (the observation/measurement):
Symptoms/clinical signs can be combined into related symptom complexes (syndromes).